Haedersdal M, Wulf H C
Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
J Eur Acad Dermatol Venereol. 2006 Jan;20(1):9-20. doi: 10.1111/j.1468-3083.2005.01327.x.
Unwanted hair growth remains a therapeutic challenge and there is a considerable need for an effective and safe treatment modality.
From an evidence-based view to summarize efficacy and adverse effects from hair removal with ruby, alexandrite, diode, and Nd:YAG lasers and intense pulsed light (IPL).
Original publications of controlled clinical trials were identified in Medline and the Cochrane Library.
A total of 9 randomized controlled (RCTs) and 21 controlled trials (CTs) were identified. The best available evidence was found for the alexandrite (three RCTs, eight CTs) and diode (three RCTs, four CTs) lasers, followed by the ruby (two RCTs, six CTs) and Nd:YAG (two RCTs, four CTs) lasers, whereas limited evidence was available for IPL sources (one RCT, one CT). Based on the present best available evidence we conclude that (i) epilation with lasers and light sources induces a partial short-term hair reduction up to 6 months postoperatively, (ii) efficacy is improved when repeated treatments are given, (iii) efficacy is superior to conventional treatments (shaving, wax epilation, electrolysis), (iv) evidence exists for a partial long-term hair removal efficacy beyond 6 months postoperatively after repetitive treatments with alexandrite and diode lasers and probably after treatment with ruby and Nd:YAG lasers, whereas evidence is lacking for long-term hair removal after IPL treatment, (v) today there is no evidence for a complete and persistent hair removal efficacy, (vi) the occurrence of postoperative side-effects is reported low for all the laser systems.
The evidence from controlled clinical trials favours the use of lasers and light sources for removal of unwanted hair. We recommend that patients are pre-operatively informed of the expected treatment outcome.
毛发过多仍是一个治疗难题,因此迫切需要一种有效且安全的治疗方式。
从循证医学的角度总结红宝石激光、翠绿宝石激光、半导体激光、掺钕钇铝石榴石激光及强脉冲光(IPL)脱毛的疗效及不良反应。
在Medline和Cochrane图书馆中检索对照临床试验的原始文献。
共检索到9项随机对照试验(RCT)和21项对照试验(CT)。翠绿宝石激光(3项RCT,8项CT)和半导体激光(3项RCT,4项CT)的现有证据最佳,其次是红宝石激光(2项RCT,6项CT)和掺钕钇铝石榴石激光(2项RCT,4项CT),而IPL光源的证据有限(1项RCT,1项CT)。基于目前最佳的现有证据,我们得出以下结论:(i)激光和光源脱毛术后6个月内可使毛发部分短期减少;(ii)重复治疗可提高疗效;(iii)疗效优于传统治疗方法(剃须、蜡脱毛、电解脱毛);(iv)有证据表明,翠绿宝石激光和半导体激光重复治疗后,术后6个月以上有部分长期脱毛效果,红宝石激光和掺钕钇铝石榴石激光治疗后可能也有此效果,而IPL治疗后缺乏长期脱毛的证据;(v)目前没有证据表明有完全持久的脱毛效果;(vi)所有激光系统术后副作用的发生率均较低。
对照临床试验的证据支持使用激光和光源去除多余毛发。我们建议术前告知患者预期的治疗效果。